Egypt-based life science startup Nawah Scientific has sold a strategic stake to Essam Abdelhadi, the former vice president Middle East, Turkey, Africa and Pakistan of Abbott, a US-based healthcare multinational, ahead of its upcoming Series A round. Founded in 2015, Nawah Scientific is an online platform that receives experiment requests, collects samples, conducts tests and returns results digitally. Its aim is to enable scientists to conduct higher quality research, regardless of their location and owned lab facilities. The startup has established itself as an integral part of Egypt’s pharmaceutical industry and has so far analysed over 50,000 samples from more than 3,000 clients in nine countries. Having concluded a US$1 million pre-Series A round earlier in the year, Nawah Scientific is now working on a Series A, and has part of that has secured backing from Abdelhadi and added him to its advisory board. The startup recently expanded to Jordan and is also growing its offerings to pharmaceutical companies to include formulation development, stability studies, as well as all raw material and finished products quality control checks.
SOURCE: DISRUPT AFRICA
More Stories
The Marshall Nature Reserve Gives a Different Glimpse of the Sudanese Capital
The Journey of Moving Tanzanians Around
Correcting Kinshasa’s Commodity Crisis
Can African Leaders Rate Themselves?
First Black African to Win Grand Tour Stage
Financing Dangote’s Fertiliser Dream Tougher than Expected
This is a Moment for the Women of Kenya
US Support in Somalia Couldn’t Have Come at a Better Time
A Symbol of Sudan’s Resistance
Families of Trapped Miners in Limbo
Google Translate Announces an Addition of 10 Languages Spoken in Africa
All Four Tourists Reported Missing in the Fish River Canyon have been Accounted For